Plasma Amyloid Concentration in Alzheimer’s Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer’s Disease Cases from Controls
出版年份 2020 全文链接
标题
Plasma Amyloid Concentration in Alzheimer’s Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer’s Disease Cases from Controls
作者
关键词
-
出版物
JOURNAL OF ALZHEIMERS DISEASE
Volume 74, Issue 4, Pages 1285-1294
出版商
IOS Press
发表日期
2020-03-14
DOI
10.3233/jad-200046
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes
- (2019) Matthew P. Pase et al. JAMA Neurology
- Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2019) Valery L Feigin et al. LANCET NEUROLOGY
- Cerebrospinal Fluid and Plasma Biomarkers in Neurodegenerative Diseases
- (2019) Yusuke Seino et al. JOURNAL OF ALZHEIMERS DISEASE
- Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
- (2019) Gil D. Rabinovici et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Amyloid PETs are commonly negative in suspected Alzheimer’s disease with an increase in CSF phosphorylated-tau protein concentration but an Aβ42 concentration in the very high range: a prospective study
- (2019) Chloé Manca et al. JOURNAL OF NEUROLOGY
- Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project
- (2019) Ingrid S. van Maurik et al. Alzheimers Research & Therapy
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
- (2019) Sebastian Palmqvist et al. JAMA Neurology
- Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
- (2019) Virginia Pérez-Grijalba et al. Alzheimers Research & Therapy
- Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease
- (2019) Szu-Ying Lin et al. Alzheimers Research & Therapy
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Will biomarker-based diagnosis of Alzheimer’s disease maximize scientific progress? Evaluating proposed diagnostic criteria
- (2018) Medellena Maria Glymour et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study
- (2018) Jin Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Impact of Amyloid PET Imaging in the Memory Clinic: A Systematic Review and Meta-Analysis
- (2018) Yat-Fung Shea et al. JOURNAL OF ALZHEIMERS DISEASE
- Technological advances and changing indications for lumbar puncture in neurological disorders
- (2018) Joost M Costerus et al. LANCET NEUROLOGY
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study
- (2018) Saima Hilal et al. Alzheimers Research & Therapy
- Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes
- (2018) Inge M.W. Verberk et al. ANNALS OF NEUROLOGY
- Long-Term Stability of Alzheimer's Disease Biomarker Proteins in Cerebrospinal Fluid
- (2018) Carola G. Schipke et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid Clearance as a Treatment Target Against Alzheimer's Disease
- (2018) Alexander Kurz et al. JOURNAL OF ALZHEIMERS DISEASE
- Meta-Analysis of Plasma Amyloid-β levels in Alzheimer's Disease
- (2018) Fei Song et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Plasma tau/amyloid-β1–42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer’s disease
- (2018) Jong-Chan Park et al. BRAIN
- Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
- (2018) Itziar de Rojas et al. Alzheimers Research & Therapy
- Plasma Amyloid-β Levels, Cerebral Small Vessel Disease, and Cognition: The Rotterdam Study
- (2017) Saima Hilal et al. JOURNAL OF ALZHEIMERS DISEASE
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Amyloid-β and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline
- (2017) P. Hemachandra Reddy et al. JOURNAL OF ALZHEIMERS DISEASE
- Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study
- (2016) Flora H. Duits et al. Alzheimers & Dementia
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma
- (2016) Virginia Pérez-Grijalba et al. JOURNAL OF ALZHEIMERS DISEASE
- Association of Plasma β-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease
- (2016) Janine Gronewold et al. MOLECULAR NEUROBIOLOGY
- The ARIC-PET amyloid imaging study
- (2016) Rebecca F. Gottesman et al. NEUROLOGY
- Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
- (2016) Maowen Ba et al. Translational Neurodegeneration
- Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study
- (2015) Vincent Chouraki et al. Alzheimers & Dementia
- The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey
- (2015) Martina Bocchetta et al. Alzheimers & Dementia
- Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
- (2015) Courtney L. Sutphen et al. JAMA Neurology
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- β-Amyloid Dynamics in Human Plasma
- (2012) Yafei Huang et al. ARCHIVES OF NEUROLOGY
- Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline
- (2011) Kristine Yaffe JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma β-Amyloid and Cognitive Decline
- (2010) Stephanie A. Cosentino et al. ARCHIVES OF NEUROLOGY
- PET imaging of brain amyloid in dementia: a review
- (2010) Harriet Quigley et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Biological markers of amyloid β-related mechanisms in Alzheimer's disease
- (2009) Harald Hampel et al. EXPERIMENTAL NEUROLOGY
- Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
- (2009) Guojun Bu NATURE REVIEWS NEUROSCIENCE
- Peripheral A subspecies as risk biomarkers of Alzheimer's disease
- (2008) N. Schupf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine
- (2006) Imrich Blasko et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now